首页 | 本学科首页   官方微博 | 高级检索  
     

2001~2005年江苏省盐都区病毒性肝炎血清流行病学监测
引用本文:曹桂华,张毓鑫,杨书宏,陈万庚. 2001~2005年江苏省盐都区病毒性肝炎血清流行病学监测[J]. 疾病监测, 2006, 21(11): 577-581. DOI: 10.3784/j.issn.1003-9961.2006.11.577
作者姓名:曹桂华  张毓鑫  杨书宏  陈万庚
作者单位:江苏省盐城市盐都区疾病预防控制中心,江苏,盐城,224002;江苏省盐城市盐都区疾病预防控制中心,江苏,盐城,224002;江苏省盐城市盐都区疾病预防控制中心,江苏,盐城,224002;江苏省盐城市盐都区疾病预防控制中心,江苏,盐城,224002
摘    要:目的研究一般人群血清病毒性肝炎免疫水平。方法在省级病毒性肝炎血清流行病学监测点内分别于2001、2003、2005年对一般人群免疫水平进行血清流行病学监测,用酶联免疫吸附法(ELISA)检测抗-HAV-IgG、HBsAg、抗-HBs、抗-HBc、抗-HCV等。结果抗-HAV-IgG总阳性检出率为82.38%,HBsAg总阳性检出率2.79%,抗-HBs总阳性检出率57.04%,抗-HBc总阳性检出率46.94%,抗-HCV总阳性检出率0.08%。结论一般人群甲型肝炎抗体较高,表明有关控制甲型肝炎的干预措施切实有效。乙型肝炎防治措施的重点应为,加强对10 ̄20岁年龄组的疫苗接种。

关 键 词:一般人群  病毒性肝炎  免疫水平  血清流行病学  监测
文章编号:1003-9961(2006)10-0577-04
收稿时间:2006-04-24
修稿时间:2006-04-242006-07-08

Seroepidemiological surveillance of viral hepatitis in Yandu District from 2001 to 2005
CAO Gui-hua,ZHANG Yu-xin,YANG Shu-hong,CHEN Wan-geng. Seroepidemiological surveillance of viral hepatitis in Yandu District from 2001 to 2005[J]. Disease Surveillance, 2006, 21(11): 577-581. DOI: 10.3784/j.issn.1003-9961.2006.11.577
Authors:CAO Gui-hua  ZHANG Yu-xin  YANG Shu-hong  CHEN Wan-geng
Affiliation:1.Yandu District CDC of Yancheng City;Jiangsu Province;Yandu 224002 China;
Abstract:Objective The present study was conducted to get the knowledge of the serum immune level of general population against viral hepatitis. Methods Seroepidemiological surveillance was conducted on immune level of general population at provincial seroepidemiological surveillance spots for viral hepatitis in 2001, 2003, 2005 respectively. ELISA was adopted to detect HAV-IgG antibody, HBs antigen, HBs antibody, HBc antibody, HCV antibody and so on. Results The total positive detection rates of HAV-IgG antibody, HBs antigen, HBs antibody, HBc antibody and HCV antibody were respectively 82.38%, 2.79%, 57.04%, 46.94% and 0.08%. Conclusion In general population, the level of Type A Hepatitis antibody was relatively high, which showed that the intervention measures to control Type A Hepatitis was quite effective. And the key point of the prevention and control of Type B Hepatitis should be to strengthen vaccination in the group aged 10~20.
Keywords:general population  viral hepatitis  immune level  seroepidemiology  surveillance
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《疾病监测》浏览原始摘要信息
点击此处可从《疾病监测》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号